Cooper Companies (COO) Other Non-Current Assets (2009 - 2026)
Cooper Companies (COO) recorded quarterly Other Non-Current Assets of $672.8 million in Q2 2026, down 2.27% quarter-over-quarter from $688.4 million in Q1 2026, and up 2.09% year-on-year from $659.0 million in Q2 2025.
Cooper Companies (COO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $672.8 million for Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 2.09% year-over-year to $672.8 million; the trailing twelve-month figure through Apr 2026 stood at $672.8 million (up 2.09% YoY), and the FY2025 full-year result was $689.2 million, up 4.33% from the prior year.
- Other Non-Current Assets was $672.8 million for Q2 2026 at Cooper Companies, down from $688.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $689.2 million in Q4 2025 and troughed at $169.0 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $632.6 million (2023), against an average of $575.6 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 559.08% in 2022, then decreased 1.08% in 2024.
- Year by year, Other Non-Current Assets stood at $587.9 million in 2022, then increased by 8.37% to $637.1 million in 2023, then increased by 3.69% to $660.6 million in 2024, then climbed by 4.33% to $689.2 million in 2025, then slipped by 2.38% to $672.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $672.8 million in Q2 2026, $688.4 million in Q1 2026, and $689.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 159.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 672.80 Mn |
| Jan 31, 2026 | 688.40 Mn |
| Oct 31, 2025 | 689.20 Mn |
| Jul 31, 2025 | 653.30 Mn |
| Apr 30, 2025 | 659.00 Mn |
| Jan 31, 2025 | 663.70 Mn |
| Oct 31, 2024 | 660.60 Mn |
| Jul 31, 2024 | 621.40 Mn |
| Apr 30, 2024 | 637.20 Mn |
| Jan 31, 2024 | 616.90 Mn |
| Oct 31, 2023 | 637.10 Mn |
| Jul 31, 2023 | 628.20 Mn |
| Apr 30, 2023 | 584.80 Mn |
| Jan 31, 2023 | 568.80 Mn |
| Oct 31, 2022 | 587.90 Mn |
| Jul 31, 2022 | 306.00 Mn |
| Apr 30, 2022 | 317.40 Mn |
| Jan 31, 2022 | 169.00 Mn |
| Oct 31, 2021 | 89.20 Mn |
| Jul 31, 2021 | 88.10 Mn |